CACLP - The largest IVD Expo & Conference

PBD Biotech Gains £2.4M Investment for TB Blood Test Development

Industry news | 18 October, 2022 | CACLP

Original from: Genoemweb


PBD Biotech said Monday it gained investment funding of £2.4 million ($2.7 million) to support clinical trials for its Actiphage rapid screening test for latent tuberculosis infections and their potential to develop into serious disease. 


Fund managers Mercia and the Foresight Group led a consortium that provided the funding, along with additional private investors and the University of Nottingham, through the European Union-backed Midlands Engine Investment Fund.


Nottingham, UK-based PBD Biotech said the test uses phage-induced lysis of Mycobacterium tuberculosis in a blood sample to allow molecular detection of the bacteria's DNA. Citing clinical study results from the Leicester Respiratory NIHR Biomedical Centre, PBD said research so far indicates the assay can be used to diagnose individuals with pulmonary TB and identify early-stage infections that could develop into disease. The assay provides results in less than one hour. 


"By enabling rapid screening of a population for TB, Actiphage offers a breakthrough in disease prevention and treatment," PBD said. "Further trials of Actiphage are currently running in the UK, South Africa, and Zambia."


Data presented earlier this year at the European Congress of Clinical Microbiology and Infectious Diseases suggested that live M. tuberculosis could be detected in blood and that the Actiphage assay could identify patients at risk of active TB with higher specificity and similar sensitivity to the current gold standard, interferon-gamma release assays.


Source: PBD Biotech Gains £2.4M Investment for TB Blood Test Development

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference